GlassScriptPhysician profile
Scott Matthew Martin
NPI 1386622462
$5,845.49
in general payments reported to CMS, 2019-2025
16 companies · $46.03 in 2025
The $46.03 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,507 · 2020: $1,814 · 2021: $1,072 · 2022: $342 · 2023: $680 · 2024: $384 · 2025: $46.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,110.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,631.32 | 2019-2025 | Proclaim, Octrode, Penta |
| Stryker Corporation | $232.23 | 2019-2023 | Mako |
| Revance Therapeutics, INC. | $176.52 | 2024 | Daxxify |
| Nevro Corp. | $169.29 | 2020 | |
| Goode Surgical INC | $160.03 | 2021 | |
| Novo Nordisk INC | $124.80 | 2019 | |
| Merz North America, INC. | $98.00 | 2023 | Xeomin |
| Shire North American Group INC | $75.57 | 2019 | |
| Dexcom, INC. | $54.49 | 2020 | |
| Arbor Pharmaceuticals, INC. | $23.00 | 2019 | |
| Amgen INC. | $21.74 | 2019 | |
| Antares Pharma, INC. | $21.48 | 2019 | |
| Acera Surgical, INC. | $15.20 | 2025 | Restrata Wound Matrix |
| Janssen Pharmaceuticals, INC | $14.33 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.29 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maxx Orthopedics, INC. | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.